Health Care Reform Reaches Crucial Stage; Physician Payment Cuts Scheduled to Begin April 1
|
Endocrine Insider The Endocrine Society is closely following the debate on health reform in part due to a provision included in the Senate bill that addresses payment cuts to dual energy x-ray absorptiometry (DXA) services provided in physicians’ offices. DXA payments have been cut by 67 percent since 2007, and the proposal in the Senate health reform bill would restore payments for two years to 70 percent of the 2006 payment rate to approximately $98. The proposal also instructs the Institute of Medicine to perform a study on the impact on patient access to DXA services due to the cuts. In 2009, The Endocrine Society developed a set of guiding principles for health reform outlining the Society’s key issues for inclusion in any health reform proposal. These guiding principles have been used as a basis for the Society’s communication with House and Senate leadership regarding the various health reform bills that have been proposed throughout the past year. Physician Payment Cuts The most recent short-term fix was passed in early March and is scheduled to end on April 1. Last week, the Senate passed legislation that would again delay physician payment cuts until October 1. The bill now goes to the House for passage, where the inclusion of amendments will likely require both houses to vote again on the amended bill. As such, it is unlikely that both houses will be able to approve this most recent fix by the April 1 deadline to avert the scheduled 21.2 percent physician payment cut. If this is the case, CMS will likely instruct Medicare contractors to hold all claims for payment for a few days to give Congress an opportunity to pass the short-term fix. It is unlikely that Congress to will address a longer-term fix to the SGR this year. The Endocrine Society continues to press Congress for a longer-term fix to the SGR and encourages its members to contact their members of Congress to express their disapproval and frustration with the current payment system. Stay tuned to Endocrine Insider for new developments as they occur. |
